









Markets
/
Stocks
/
nasdaq-foxo
/

Foxo Technologies Inc

FOXO

View Detailed Chart

1.570USD

+0.933+146.82%

Close 05/09, 16:00（ET）Quotes delayed by 15 min

36.99MMarket Cap

--P/E TTM



Foxo Technologies Inc

1.570

+0.933+146.82%

Company

Intraday

30m

Today

+146.82%

5 Days

+96.62%

1 Month

+13.19%

6 Months

+216.53%

Year to Date

+438.96%

1 Year

+473.20%

View Detailed Chart

Agency Rating

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(2)

Neutral(5)

Buy(6)

Indicators

Sell(2)

Neutral(5)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.017

Neutral

RSI(14)

51.462

Neutral

STOCH(KDJ)(9,3,3)

57.972

Neutral

ATR(14)

0.233

High Vlolatility

CCI(14)

23.005

Neutral

Williams %R

46.992

Neutral

TRIX(12,20)

-1.251

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

0.784

Buy

MA10

0.392

Buy

MA20

0.709

Buy

MA50

0.468

Buy

MA100

0.374

Buy

MA200

0.320

Buy

News

More news coming soon, stay tuned...

Company

FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.

Company codeFOXO

CompanyFoxo Technologies Inc

CEOMr. Seamus Lagan

Websitehttp://delwinds.com/